Literature DB >> 2844998

Regional distribution of the GABAA/benzodiazepine receptor (alpha subunit) mRNA in rat brain.

P Montpied1, B M Martin, S L Cottingham, B K Stubblefield, E I Ginns, S M Paul.   

Abstract

A human cDNA clone containing the 5' coding region of the GABAA/benzodiazepine receptor alpha subunit was used to quantify and visualize receptor mRNA in various regions of the rat brain. Using a [32P]CTP-labelled antisense RNA probe (860 bases) prepared from the alpha subunit cDNA, multiple mRNA species were detected in Northern blots using total and poly A rat brain RNA. In all brain regions, mRNAs of 4.4 and 4.8 kb were observed, and an additional mRNA of 3.0 kb was detected in the cerebellum and hippocampus. The level of GABAA/benzodiazepine receptor mRNA was highest in the cerebellum followed by the thalamus = frontal cortex = hippocampus = parietal cortex = hypothalamus much greater than pons = striatum = medulla. In situ hybridization revealed high levels of alpha subunit mRNA in cerebellar gray matter, olfactory bulb, thalamus, hippocampus/dentate gyrus, and the arcuate nucleus of the hypothalamus. These data suggest the presence of multiple GABAA/benzodiazepine receptor alpha subunit mRNAs in rat brain and demonstrate the feasibility of studying the expression of genes encoding the GABAA/benzodiazepine receptor after pharmacological and/or environmental manipulation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2844998     DOI: 10.1111/j.1471-4159.1988.tb01137.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  10 in total

1.  Isolation and characterization of endogenous modulators for GABA system.

Authors:  M Yarom; J Bao; X W Tang; E Wu; Y H Lee; W H Tsai; J Y Wu
Journal:  Neurochem Res       Date:  1992-01       Impact factor: 3.996

2.  GABAA Receptor Density Is Not Altered by a Novel Herbal Anxiolytic Treatment.

Authors:  Ravid Doron; Avital Sever; Assaf Handelsman; Roni Toledano; Motty Franko; Yafit Hirshler; Alon Shamir; Or Burstein; Moshe Rehavi
Journal:  J Mol Neurosci       Date:  2018-05-08       Impact factor: 3.444

Review 3.  Ligand-gated ion channels. Homology and diversity.

Authors:  V B Cockcroft; D J Osguthorpe; E A Barnard; A E Friday; G G Lunt
Journal:  Mol Neurobiol       Date:  1990 Fall-Winter       Impact factor: 5.590

Review 4.  Autoradiographical and immunohistochemical analysis of receptor localization in the central nervous system.

Authors:  J G Chabot; S Kar; R Quirion
Journal:  Histochem J       Date:  1996-11

5.  Structure and function of L-glutamate decarboxylase.

Authors:  J Y Wu; W M Huang; L Reed-Fourquet; J Bao; B Nathan; E Wu; W H Tsai
Journal:  Neurochem Res       Date:  1991-03       Impact factor: 3.996

6.  Subunit- and brain region-specific reduction of GABAA receptor subunit mRNAs during chronic treatment of rats with diazepam.

Authors:  Y Wu; H C Rosenberg; T H Chiu; T J Zhao
Journal:  J Mol Neurosci       Date:  1994       Impact factor: 3.444

7.  Combined pharmacological and electrophysiological dissociation of familiarity and recollection.

Authors:  Tim Curran; Casey DeBuse; Brion Woroch; Elliot Hirshman
Journal:  J Neurosci       Date:  2006-02-15       Impact factor: 6.167

8.  An autoradiographic study comparing the interactions of 3 alpha-OH-5 alpha-pregnan-20-one, pregnenolone sulfate and pentobarbital with [3S]-TBPS binding sites and their modulation by GABA in different structures of the rat brain.

Authors:  M Vincens; E Dartois; E Moyse; F Haour; G Fillion
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-04       Impact factor: 3.000

9.  Midazolam, hippocampal function, and transitive inference: Reply to Greene.

Authors:  Michael J Frank; Randall C O'Reilly; Tim Curran
Journal:  Behav Brain Funct       Date:  2008-01-30       Impact factor: 3.759

10.  Implicit transitive inference and the human hippocampus: does intravenous midazolam function as a reversible hippocampal lesion?

Authors:  Anthony J Greene
Journal:  Behav Brain Funct       Date:  2007-09-24       Impact factor: 3.759

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.